Interesting research being undertaken by Barbara Guinn, Head of Biomedical Sciences, University of Hull in The Conversation.com. “A urine test for ovarian cancer could increase survival rates from 20% to 90%.”
This is why it’s so important that the quality of specimens allows for right-first-time diagnosis and that appropriate treatment follows.
A new study shows that Antibiotic-resistant UTI bacteria is becoming more common; Knowlex has created a short-film about the research and what you should know about this worrying dilemma.
49% of AMR increase has a urinary source. Health policy makers must stop overlooking basic specimen collection and create a protocol for use.
We’ve been an advocate for the MUST Campaign since they launched in May and this article explains why it is so important.
Read about it in this article published today on AgeSpace.com
Barry Shrier, Founder of annual health innovation event Giant Live, presents the third Disruptor Giant Health Innovators TV interview featuring Giovanna Forte, CEO of Forte Medical, Francis White from AliveCor, Dr Sophie Bostock of Sleepio and Etienne Bourdon from Healthy Health. Watch the half-hour programme here with Disruptive Live
Despite its importance, there is no standard for urine collection. In this article the author, Professor Frank Chinegwundoh, discusses the problem of inadequate samples and describes a collection system that can help. Visit the Jan-Feb issue of Trends in Urology & Men’s Health.
We have been talking prevention for some time so are pleased to see this report from Public Health England advocating right-first-time devices.
The Hippocratic Post is a widely read blog engine for GPs and other physicians. Our Peezy Midstream technology has been acknowledged as a credible method of reducing the huge variation in urine specimen quality. Read all about it here.
Forte Medical Forum
26th September 2017, 0900-1400hrs
Royal College of Physicians, London
Our second annual Forum highlights the urgent need for a urine collection gold standard; disparate methods in use across the UK result in contamination rates that range from 0.3% to over 70%, making successful urine-based diagnostics a national lottery. Come and meet leading NHS and other game-changers who gather here to present the case for accurate basic medicine, without which Hospital Acquired Infection and Antimicrobial Resistance cannot be successfully challenged. Register at Eventbrite.
MAMA Academy is a leading charity that provides mothers and midwives with unbiased education, research and information around pregnancy and the arrival of the next generation. Forte Medical is delighted to feature in MAMA Academy’s latest news post about accurate antenatal screening; click the link and read all about the importance of reliable antenatal urine testing.